Biogen Inc. BIIB
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Andrew Tsai | Jefferies | 137.67 $ | 190 $ | 52.33 % | 25/09/2025 |
| Brian Abrahams | RBC Capital | 127.31 $ | 213 $ | 85.69 % | 25/06/2025 |
| Andrew Fein | H.C. Wainwright | 122.41 $ | 187 $ | 64.59 % | 05/05/2025 |
| Jay Olson | Oppenheimer | 123.53 $ | 205 $ | 81.47 % | 02/05/2025 |
| Sumant Kulkarni | Canaccord Genuity | 138.06 $ | 265 $ | 126.94 % | 13/02/2025 |
| Mohit Bansal | Wells Fargo | 133.43 $ | 165 $ | 31.57 % | 12/02/2025 |
| Geoff Meacham | Citigroup | 133.43 $ | 160 $ | 26.57 % | 12/02/2025 |
| Ami Fadia | Needham | 133.43 $ | 270 $ | 136.57 % | 12/02/2025 |
| Michael Yee | Jefferies | 157.78 $ | 180 $ | 22.22 % | 09/12/2024 |
| Brian Skorney | Robert W. Baird | 162.83 $ | 300 $ | 137.17 % | 15/11/2024 |
| Jay Olson | Oppenheimer | 181.18 $ | 255 $ | 73.82 % | 31/10/2024 |
| Terence Flynn | Morgan Stanley | 181.18 $ | 204 $ | 22.82 % | 31/10/2024 |
| Christopher Raymond | Raymond James | 181.18 $ | 315 $ | 133.82 % | 30/10/2024 |
| Salveen Richter | Goldman Sachs | 181.18 $ | 290 $ | 108.82 % | 30/10/2024 |
| Evan Seigerman | BMO Capital | 188.165 $ | 230 $ | 41.84 % | 17/10/2024 |
| Ashwani Verma | UBS | 188.74 $ | 202 $ | 13.26 % | 03/10/2024 |
| Laura Chico | Wedbush | 199.36 $ | 205 $ | 5.64 % | 23/09/2024 |
| Brian Skorney | Robert W. Baird | 212.7 $ | 294 $ | 81.30 % | 29/07/2024 |
| Salveen Richter | Goldman Sachs | 211.17 $ | 342 $ | 130.83 % | 26/07/2024 |
| Christopher Raymond | Piper Sandler | 211.17 $ | 307 $ | 95.83 % | 26/07/2024 |
| Brian Abrahams | RBC Capital | 214.16 $ | 282 $ | 67.84 % | 26/07/2024 |
| Christopher Raymond | Piper Sandler | 236.8 $ | 313 $ | 76.20 % | 12/07/2024 |
| Terence Flynn | Morgan Stanley | 232.75 $ | 311 $ | 78.25 % | 11/07/2024 |
| George Farmer | Scotiabank | 230.28 $ | 275 $ | 44.72 % | 12/06/2024 |
| Evan David Seigerman | BMO Capital | 220 $ | 260 $ | 40.00 % | 23/05/2024 |
| Paul Matteis | Stifel Nicolaus | 225.21 $ | 275 $ | 49.79 % | 22/05/2024 |
| Christopher Raymond | Raymond James | 225.21 $ | 335 $ | 109.79 % | 22/05/2024 |
| Matthew Harrison | Morgan Stanley | 224.48 $ | 331 $ | 106.52 % | 22/05/2024 |
| Laura Chico | Wedbush | 204.65 $ | 215 $ | 10.35 % | 25/04/2024 |
| Andrew Fein | H.C. Wainwright | 201.99 $ | 300 $ | 98.01 % | 25/04/2024 |
| Brian Abrahams | RBC Capital | 201.99 $ | 317 $ | 115.01 % | 25/04/2024 |
| Jay Olson | Oppenheimer | 190.52 $ | 270 $ | 79.48 % | 19/04/2024 |
| Carter Gould | Barclays | 206.38 $ | 215 $ | 8.62 % | 03/04/2024 |
| Laura Chico | Wedbush | 271.23 $ | 269 $ | -2.23 % | 07/08/2023 |
| Yatin Suneja | Guggenheim | 311.11 $ | 350 $ | 38.89 % | 01/05/2023 |
| Steve Chesney | Atlantic Equities | 271.165 $ | 200 $ | -71.17 % | 28/09/2022 |
| Matthew Harrison | Morgan Stanley | 271.135 $ | 285 $ | 13.87 % | 28/09/2022 |
| Ami Fadia | Needham | 271.165 $ | 250 $ | -21.17 % | 28/09/2022 |
| Evan David Seigerman | BMO Capital | 197.79 $ | 360 $ | 162.21 % | 28/09/2022 |
| Salim Syed | Mizuho Securities | 197.79 $ | 270 $ | 72.21 % | 28/09/2022 |
| Brian Skorney | Robert W. Baird | 197.79 $ | 340 $ | 142.21 % | 28/09/2022 |
| Ami Fadia | Needham | 197.79 $ | 250 $ | 52.21 % | 28/09/2022 |
| Mohit Bansal | Wells Fargo | 212.55 $ | 265 $ | 52.45 % | 18/04/2022 |
| Carter Gould | Barclays | 212.55 $ | 219 $ | 6.45 % | 17/04/2022 |
| Ami Fadia | Needham | 210.62 $ | 262 $ | 51.38 % | 11/04/2022 |
| Laura Chico | Wedbush | 214.75 $ | 185 $ | -29.75 % | 09/04/2022 |
| Michael Yee | Jefferies | 211.64 $ | 300 $ | 88.36 % | 07/04/2022 |
| Brian Skorney | Robert W. Baird | 211.64 $ | 224 $ | 12.36 % | 07/04/2022 |
| Christopher Raymond | Piper Sandler | 211.64 $ | 200 $ | -11.64 % | 07/04/2022 |
| Brian Abrahams | RBC Capital | 207.61 $ | 244 $ | 36.39 % | 05/04/2022 |
| Geoff Meacham | Bank of America Securities | 211.68 $ | 225 $ | 13.32 % | 28/03/2022 |
| Evan Seigerman | BMO Capital | 197.36 $ | 238 $ | 40.64 % | 15/03/2022 |
| Sumant Kulkarni | Canaccord Genuity | 211.01 $ | 285 $ | 73.99 % | 28/02/2022 |
| Yatin Suneja | Guggenheim | 209.81 $ | 200 $ | -9.81 % | 22/02/2022 |
| Robyn Karnauskas | Truist Financial | 214.55 $ | 320 $ | 105.45 % | 16/02/2022 |
| Ami Fadia | Needham | 214.589996 $ | 290 $ | 75.41 % | 13/02/2022 |
| Salim Syed | Mizuho Securities | 221.3 $ | 207 $ | -14.30 % | 07/02/2022 |
| Carter Gould | Barclays | 221.53 $ | 235 $ | 13.47 % | 04/02/2022 |
| Mohit Bansal | Wells Fargo | 221.53 $ | 235 $ | 13.47 % | 04/02/2022 |
| Tim Anderson | Wolfe Research | 221.53 $ | 217 $ | -4.53 % | 04/02/2022 |
| Matthew Harrison | Morgan Stanley | 221.53 $ | 330 $ | 108.47 % | 04/02/2022 |
| Phil Nadeau | Cowen & Co. | 221.53 $ | 285 $ | 63.47 % | 04/02/2022 |
| Cory Kasimov | J.P. Morgan | 220.17 $ | 236 $ | 15.83 % | 03/02/2022 |
| Ami Fadia | Needham | 225.210007 $ | 292 $ | 66.79 % | 30/01/2022 |
| Michael Yee | Jefferies | 239.300003 $ | 325 $ | 85.70 % | 16/01/2022 |
| Alethia Young | Cantor Fitzgerald | 225.34 $ | 209 $ | -16.34 % | 12/01/2022 |
| Aaron Gal | Bernstein | 244.14 $ | 400 $ | 155.86 % | 03/01/2022 |
| Salveen Richter | Goldman Sachs | 224.11 $ | 271 $ | 46.89 % | 06/12/2021 |
| Colin Bristow | UBS | 266.57 $ | 405 $ | 138.43 % | 20/10/2021 |
| Steve Chesney | Atlantic Equities | 395.37 $ | 415 $ | 19.63 % | 08/06/2021 |